The use of propofol for induction in critically ill patients was independently associated with an increased risk of peri-intubation cardiovascular instability/collapse (OR 1.23; 95% CI 1.02-1.49).
Cohort (n=2,760)
Yes
Does the use of propofol for induction increase the risk of peri-intubation cardiovascular instability/collapse in critically ill patients?
Peri-intubation cardiovascular collapse is common in critically ill patients and is independently associated with the use of propofol for induction.
Odds Ratio: 1.23 (95% CI 1.02–1.49)
Abstract Rationale Cardiovascular instability/collapse is a common peri-intubation event in patients who are critically ill. Objectives To identify potentially modifiable variables associated with peri-intubation cardiovascular instability/collapse (i.e., systolic arterial pressure 65 mm Hg once or 90 mm Hg for 30 minutes; new/increased vasopressor requirement; fluid bolus 15 ml/kg, or cardiac arrest). Methods INTUBE (International Observational Study to Understand the Impact and Best Practices of Airway Management In Critically Ill Patients) was a multicenter prospective cohort study of patients who were critically ill and undergoing tracheal intubation in a convenience sample of 197 sites from 29 countries across five continents from October 1, 2018, to July 31, 2019. Measurements and Main Results A total of 2,760 patients were included in this analysis. Peri-intubation cardiovascular instability/collapse occurred in 1,199 out of 2,760 patients (43.4%). Variables associated with this event were older age (odds ratio OR, 1.02; 95% confidence interval CI, 1.02–1.03), higher heart rate (OR, 1.008; 95% CI, 1.004–1.012), lower systolic blood pressure (OR, 0.98; 95% CI, 0.98–0.99), lower oxygen saturation as measured by pulse oximetry/Fi O2 before induction (OR, 0.998; 95% CI, 0.997–0.999), and the use of propofol as an induction agent (OR, 1.28; 95% CI, 1.05–1.57). Patients with peri-intubation cardiovascular instability/collapse were at a higher risk of ICU mortality with an adjusted OR of 2.47 (95% CI, 1.72–3.55), P 0.001. The inverse probability of treatment weighting method identified the use of propofol as the only factor independently associated with cardiovascular instability/collapse (OR, 1.23; 95% CI, 1.02–1.49). When administered before induction, vasopressors (OR, 1.33; 95% CI, 0.84–2.11) or fluid boluses (OR, 1.17; 95% CI, 0.96–1.44) did not reduce the incidence of cardiovascular instability/collapse. Conclusions Peri-intubation cardiovascular instability/collapse was associated with an increased risk of both ICU and 28-day mortality. The use of propofol for induction was identified as a modifiable intervention significantly associated with cardiovascular instability/collapse. Clinical trial registered with clinicaltrials.gov (NCT03616054).
Russotto et al. (Tue,) conducted a cohort in Critically ill patients undergoing tracheal intubation (n=2,760). Propofol as an induction agent was evaluated on Peri-intubation cardiovascular instability/collapse (OR 1.23, 95% CI 1.02-1.49). The use of propofol for induction in critically ill patients was independently associated with an increased risk of peri-intubation cardiovascular instability/collapse (OR 1.23; 95% CI 1.02-1.49).